Luyan Pharma Co.,Ltd.

SZSE:002788 Stock Report

Market Cap: CN¥3.2b

Luyan PharmaLtd Management

Management criteria checks 3/4

Luyan PharmaLtd's CEO is Jinxiang Wu, appointed in Sep 2008, has a tenure of 16.33 years. directly owns 1.24% of the company’s shares, worth CN¥39.22M. The average tenure of the management team and the board of directors is 5.8 years and 7.3 years respectively.

Key information

Jinxiang Wu

Chief executive officer

CN¥2.1m

Total compensation

CEO salary percentagen/a
CEO tenure16.3yrs
CEO ownership1.2%
Management average tenure5.8yrs
Board average tenure7.3yrs

Recent management updates

Recent updates

The Returns On Capital At Luyan PharmaLtd (SZSE:002788) Don't Inspire Confidence

Sep 30
The Returns On Capital At Luyan PharmaLtd (SZSE:002788) Don't Inspire Confidence

CEO

Jinxiang Wu (62 yo)

16.3yrs

Tenure

CN¥2,146,400

Compensation

Mr. Jinxiang Wu serves as the Chairman of the Board of Directors and General Manager at Luyan Pharma Co.,Ltd. (formerly known as Luyan (Fujian) Pharma Co. Ltd.) Mr. Wu serves as Executive Director of Xiame...

Leadership Team

NamePositionTenureCompensationOwnership
Jinxiang Wu
Chairman & GM16.3yrsCN¥2.15m1.24%
CN¥ 39.2m
Di Wu
Deputy GM & Vice Chairman7.3yrsCN¥1.54mno data
Zheng Zeng
Financial Director & Accounting Supervisor1.3yrsCN¥58.10kno data
Lei Ming
Deputy GMno dataCN¥1.97m0.093%
CN¥ 2.9m
Qizhuan Xu
Assistant to Chairman & Director2yrsCN¥110.00kno data
Quanqing Ye
Secretary5.3yrsCN¥961.30kno data
Ming Guo Zhu
Deputy General Manager15.9yrsCN¥1.95m0.21%
CN¥ 6.5m
Wei Yang Li
Deputy General Manager15.9yrsCN¥2.08m1.04%
CN¥ 32.8m
Jun Ying Zhang
Deputy General Manager15.9yrsCN¥1.38m0.92%
CN¥ 29.2m
Jin Liu
Deputy General Manager5.8yrsCN¥1.67mno data
Cuiping Li
Internal Audit Director & Supervisorno datano data0.00031%
CN¥ 9.8k

5.8yrs

Average Tenure

49yo

Average Age

Experienced Management: 002788's management team is seasoned and experienced (5.8 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Jinxiang Wu
Chairman & GM16.3yrsCN¥2.15m1.24%
CN¥ 39.2m
Di Wu
Deputy GM & Vice Chairman7.3yrsCN¥1.54mno data
Lei Ming
Deputy GM16.3yrsCN¥1.97m0.093%
CN¥ 2.9m
Qizhuan Xu
Assistant to Chairman & Director1.3yrsCN¥110.00kno data
Cuiping Li
Internal Audit Director & Supervisor12.7yrsno data0.00031%
CN¥ 9.8k
Mei Zhen Cai
Chairman of Supervisory Board13.3yrsno data0.033%
CN¥ 1.0m
Jun Long Wu
Independent Director1.3yrsCN¥10.00kno data
Biyun Lin
Supervisor7.3yrsno data0.00071%
CN¥ 22.4k
Shaoqin Ye
Independent Director3.7yrsCN¥98.00kno data
Peilin Song
Independent Director1.3yrsCN¥10.00kno data

7.3yrs

Average Tenure

56.5yo

Average Age

Experienced Board: 002788's board of directors are considered experienced (7.3 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/20 16:35
End of Day Share Price 2025/01/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Luyan Pharma Co.,Ltd. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Andy LiuChina Stock Investment Research Co. Ltd. (GZ500..com)